FDA issues public health advisory on NEJM report

Share this article:
The FDA will issue a public health advisory based on a June 8 New England Journal of Medicine report of an increased risk of birth defects when women take ACE inhibitors during the first trimester of pregnancy. The FDA says women should stop using them as soon as possible after pregnancy is detected.
Share this article:

Email Newsletters

More in News

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.

Shire, AbbVie join forces for $55B

Shire, AbbVie join forces for $55B

The deal includes a $1.6-billion fee if AbbVie tries to walk away.

Next target for hep. C drugmakers: co-infections

Next target for hep. C drugmakers: co-infections

An international AIDS conference this weekend kicked off a new battle in the war against hepatitis C: demonstrating high cure rates in those who are co-infected.